Wain, L.V., Shrine, N., Artigas, M.S., Erzurumluoglu, A.M., Noyvert, B., Bossini-Castillo, L., Obeidat, M., Henry, A.P., Portelli, M.A. & Hall, R.J. 2017, "Genome-wide association analyses for lung function and chronic obstructive pulmonary disease identify new loci and potential druggable targets", Nature genetics, vol. 49, no. 3, pp. 416.
Grech, G., Baldacchino, S., Saliba, C., Grixti, M.P., Gauci, R., Petroni, V., Fenech, A.G. & Scerri, C. 2016, "Deregulation of the protein phosphatase 2A, PP2A in cancer: complexity and therapeutic options", Tumor Biology, vol. 37, no. 9, pp. 11691-11700.
Mizzi, C., Dalabira, E., Kumuthini, J., Dzimiri, N., Balogh, I., Başak, N., Böhm, R., Borg, J., Borgiani, P. & Bozina, N. 2016, "A european spectrum of pharmacogenomic biomarkers: implications for clinical pharmacogenomics", PLoS One, vol. 11, no. 9, pp. e0162866.
Fenech, A.G., Sayers, I. & Portelli, M.A. 2015, "Pharmacogenetics of asthma" in Preventive and Predictive Genetics: Towards Personalised Medicine Springer, , pp. 241-274.
Squassina, A., Severino, G., Grech, G., Fenech, A., Borg, J. & Patrinos, G.P. 2012, "Conference Scene: Golden Helix Pharmacogenomics Days: educational activities on pharmacogenomics and personalized medicine", Pharmacogenomics, vol. 13, no. 5, pp. 525-528.
Vidal, C., Borg, J., Fenech, A., Xuereb-anastasi, A. & Scerri, C. 2008, "A silent mutation within protectin (CD59) gene and exon skipping in a family with coeliac disease", European Journal of Human Genetics, vol. 16, no. 243, pp. P05.024.
Duroudier, N.P., Sayers, I., Castagna, C.C., Fenech, A.G., Halapi, E., Swan, C. & Hall, I.P. 2007, "Functional polymorphism and differential regulation of CYSLTR1 transcription in human airway smooth muscle and monocytes", Cell biochemistry and biophysics, vol. 47, no. 1, pp. 119-129.
Durcan, N., Costello, R.W., Graham McLean, W., Blusztajn, J., Madziar, B., Fenech, A.G., Hall, I.P., Gleich, G.J., McGarvey, L. & Walsh, M.T. 2006, "Eosinophil-mediated cholinergic nerve remodeling", American journal of respiratory cell and molecular biology, vol. 34, no. 6, pp. 775-786.
Duroudier, N.P., Fenech, A.G., Swan, C., Richards, S.A. & Hall, I.P. 2004, "Genomic organisation of the cysteinyl leukotriene receptor 1 (CLTR1) gene", British Journal of Pharmacology, .
Fenech, A.G. 2003, Polymorphic variation and transcriptional regulation of muscarinic receptor genes in human airway cells. , University of Nottingham.
Fenech, A. & Hall, I.P. 2002, "Pharmacogenetics of asthma", British journal of clinical pharmacology, vol. 53, no. 1, pp. 3-15.
Fenech, A.G., Wheatley, A., Ebejer, M.J., Felice, A.E., Ellul-Micallef, R. & Hall, I.P. 2001, "Transmission disequilibrium testing for a muscarinic M2 receptor 3’ untranslated region single nucleotide polymorphism within asthmatic families", American Journal of Respiratory and Critical Care Medicine, vol. 163, pp. A201.
Fenech, A., Ebejer, M., Felice, A., Ellul‐Micallef, R. & Hall, I. 2001, "Mutation screening of the muscarinic M2 and M3 receptor genes in normal and asthmatic subjects", British journal of pharmacology, vol. 133, no. 1, pp. 43-48.
Costello, R.W., Wheatley, A., Fenech, A., Hall, I., Calverley, P. & Ikeda, A. 2000, "Effect of polymorphisms of the M2 muscarinic receptor on vagally-induced bronchoconstriction.", American Journal of Respiratory and Critical Care Medicine, vol. 161, pp. A433.
Fenech, A.G., Wheatley, A.P., Ebejer, M.J., Felice, A.E., Ellul-Micallef, R. & Hall, I.P. 2000, "Mutation screening of the Human M2 and M3 receptor genes in normal and asthmatic individuals", British Journal of Pharmacology, .
Fenech, A., Ebejer, M., Felice, A., Ellul-Micallef, R. & Hall, I. 1999, "Mutation Screening of the Human Muscarinic M2 Receptor in Maltese Asthmatic Patients.", Br.J.Pharmacol., vol. 128, pp. 121P.